Nicolaus M Kröger

123PUBLICATIONS
475CO-AUTHORS
Predictive and prognostic markersHaematologyTransplantation immunologyCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (123)

|Oct 07, 2026
Choice of a different donor reduces relapse risk after second allogeneic SCT for MDS.

|Oct 06, 2026
GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party.

|Sep 30, 2026
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome in young adults: A retrospective study on behalf of the EBMT Chronic Malignancies Working Party.

|Jul 02, 2026
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia.

|Jun 19, 2026
The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

|Jun 12, 2026
Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

Pageof 21

Frequent Collaborators

32 joint publications

Ibrahim Yakoub-Agha

32 joint publications

Mohamad Mohty

25 joint publications

Didier Blaise

22 joint publications

Arnon Nagler